Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Health
NCT06187727Phase 4Completed
- Start
- Jul 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of henagliflozin in myocardial infarction (MI). Started Jul 2023; status: completed.
02
Drugs
henagliflozin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT06187727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06187727.